Binding modes of diketo-acid inhibitors of HIV-1 integrase: a comparative molecular dynamics simulation study.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Abstract
HIV-1 integrase (IN) has become an attractive target since drug resistance against HIV-1 reverse transcriptase (RT) and protease (PR) has appeared. Diketo acid (DKA) inhibitors are potent and selective inhibitors of HIV-1 IN: however the action mechanism is not well understood. Here, to study the inhibition mechanism of DKAs we performed 10 ns comparative molecular dynamics simulations on HIV-1 IN bound with three most representative DKA inhibitors: Shionogi inhibitor, S-1360 and two Merck inhibitors L-731,988 and L-708,906. Our simulations show that the acidic part of S-1360 formed salt bridge and cation-π interactions with Lys159. In addition, the catalytic Glu152 in S-1360 was pushed away from the active site to form an ion-pair interaction with Arg199. The Merck inhibitors can maintain either one or both of these ion-pair interaction features. The difference in potencies of the DKA inhibitors is thus attributed to the different binding modes at the catalytic site. Such structural information at atomic level, not only demonstrates the action modes of DKA inhibitors but also provides a novel starting point for structural-based design of HIV-1 IN inhibitors.Citation
Huang, M., Grant, G.H., Richards, W.G. (2011) 'Binding modes of diketo-acid inhibitors of HIV-1 integrase: a comparative molecular dynamics simulation study', Journal of molecular graphics & modelling 29 (7):956-64Publisher
ElsevierPubMed ID
21531158PubMed Central ID
PMC3101338Additional Links
https://www.sciencedirect.com/science/article/pii/S1093326311000519https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101338/
Type
ArticleLanguage
enISSN
1873-4243ae974a485f413a2113503eed53cd6c53
10.1016/j.jmgm.2011.04.002
Scopus Count
Collections
Related articles
- Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
- Authors: Hu JP, He HQ, Tang DY, Sun GF, Zhang YQ, Fan J, Chang S
- Issue date: 2013
- Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.
- Authors: Xue W, Liu H, Yao X
- Issue date: 2014
- Design, synthesis, molecular modeling, and anti-HIV-1 integrase activity of a series of photoactivatable diketo acid-containing inhibitors as affinity probes.
- Authors: Sechi M, Carta F, Sannia L, Dallocchio R, Dessì A, Al-Safi RI, Neamati N
- Issue date: 2009 Mar
- Structural determinants for HIV-1 integrase inhibition by beta-diketo acids.
- Authors: Marchand C, Zhang X, Pais GC, Cowansage K, Neamati N, Burke TR Jr, Pommier Y
- Issue date: 2002 Apr 12
- Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.
- Authors: Di Santo R, Costi R, Roux A, Artico M, Lavecchia A, Marinelli L, Novellino E, Palmisano L, Andreotti M, Amici R, Galluzzo CM, Nencioni L, Palamara AT, Pommier Y, Marchand C
- Issue date: 2006 Mar 23